| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 45.67▼ | 45.39▼ | 45.48▼ | 43.42▲ | 39.27▲ |
| MA10 | 45.59▼ | 45.44▼ | 45.44▼ | 41.15▲ | 41.97▲ |
| MA20 | 45.47▼ | 45.22▲ | 44.47▲ | 38.96▲ | 39.62▲ |
| MA50 | 45.52▼ | 43.72▲ | 42.32▲ | 42.57▲ | 32.05▲ |
| MA100 | 45.35▼ | 42.00▲ | 39.78▲ | 39.30▲ | 31.30▲ |
| MA200 | 44.48▲ | 39.40▲ | 40.01▲ | 33.87▲ | 29.06▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.013▲ | -0.108▼ | -0.054▼ | 1.130▲ | -0.627▼ |
| RSI | 40.593▼ | 57.101▲ | 65.496▲ | 64.004▲ | 58.821▲ |
| STOCH | 76.511 | 66.188 | 80.032▲ | 94.043▲ | 29.656 |
| WILL %R | -92.857▼ | -35.714 | -20.570▲ | -4.994▲ | -49.211 |
| CCI | -36.933 | 33.460 | 58.401 | 145.175▲ | -14.817 |
|
Tuesday, April 29, 2025 04:30 AM
Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States. The company’s lead product candidate is efruxifermin (EFX ...
|
|
Saturday, April 26, 2025 05:01 PM
Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...
|
|
Wednesday, April 23, 2025 05:00 PM
Sterling Capital Management LLC lifted its holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 764.3% in the 4th quarter, according to its most recent filing with the SEC.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 45.31 | 45.895 | 43.98 | 45.31 | 1,352,088 |
| 30/04/25 | 42.90 | 45.81 | 42.71 | 45.61 | 1,480,504 |
| 29/04/25 | 41.82 | 43.42 | 41.36 | 43.03 | 932,996 |
| 28/04/25 | 41.35 | 42.43 | 41.119 | 42.17 | 1,409,600 |
| 25/04/25 | 40.53 | 41.61 | 40.33 | 41.00 | 959,230 |
| 24/04/25 | 39.56 | 41.44 | 39.05 | 40.99 | 1,873,200 |
| 23/04/25 | 39.66 | 40.59 | 38.86 | 39.61 | 1,232,800 |
| 22/04/25 | 38.03 | 39.28 | 38.00 | 38.50 | 1,192,500 |
| 21/04/25 | 37.28 | 39.59 | 37.28 | 37.67 | 884,000 |
| 17/04/25 | 37.09 | 37.85 | 36.669 | 37.63 | 521,600 |
|
|
||||
|
|
||||
|
|